Clinical Trial Update: Radical Lung Radiotherapy Plus Nelfinavir [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating radical lung radiotherapy plus nelfinavir for lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN